Evaluation of human hepatocytes cultured by three-dimensional spheroid systems for drug metabolism.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Drug Metabolism and Pharmacokinetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2133/DMPK.DMPK-13-RG-105PMID 24695277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A New High-Throughput Analysis for Drug Metabolism Profiling Using Liquid Chromatography Coupled with Tandem Mass Spectrometry

  2013cited by this paper
• In Vitro Evaluation of Major In Vivo Drug Metabolic Pathways Using Primary Human Hepatocytes and HepaRG Cells in Suspension and a Dynamic Three-Dimensional Bioreactor System

  2012cited by this paper
• Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites

  2010cited by this paper
• Evaluation of the metabolism of propranolol by linear ion trap technology in mouse, rat, dog, monkey, and human cryopreserved hepatocytes.

  2009cited by this paper
• Quantitative Evaluation of the Expression and Activity of Five Major Sulfotransferases (SULTs) in Human Tissues: The SULT “Pie”

  2009cited by this paper
• Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β–induced apoptosis

  2009cited by this paper
• Preconditioned Cell Array Optimized for a Three-Dimensional Culture of Hepatocytes

  2009cited by this paper
• Preconditioned cell array optimized for a three-dimensional culture of hepatocytes.

  2009cited by this paper
• Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.

  2009cited by this paper
• Predicting circulating human metabolites: how good are we?

  2009cited by this paper
• In vitro and in vivo glucuronidation of midazolam in humans.

  2009cited by this paper
• Assessment of presystemic and systemic intestinal availability of orally administered drugs using in vitro and in vivo data in humans: intestinal sulfation metabolism impacts presystemic availability much more than systemic availability of salbutamol, SULT1A3 substrate.

  2008cited by this paper
• Contribution of the N-Glucuronidation Pathway to the Overall in Vitro Metabolic Clearance of Midazolam in Humans

  2008cited by this paper
• Evolving concepts in liver tissue modeling and implications for in vitro toxicology

  2008cited by this paper
• Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects.

  2008cited by this paper
• Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies

  2007cited by this paper
• Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.

  2007cited by this paper
• Liquid Chromatography/Tandem Mass Spectrometry Detection of Covalent Binding of Acetaminophen to Human Serum Albumin

  2007cited by this paper
• Possible Bioactivation Pathways of Lamotrigine

  2007cited by this paper
• Determination of Lamotrigine and its Metabolites in Human Plasma by Liquid Chromatography-Mass Spectrometry

  2006cited by this paper
• Effects of prototypical drug-metabolizing enzyme inducers on mRNA expression of housekeeping genes in primary cultures of human and rat hepatocytes.

  2006cited by this paper
• IN VITRO CHARACTERIZATION OF LAMOTRIGINE N2-GLUCURONIDATION AND THE LAMOTRIGINE-VALPROIC ACID INTERACTION

  2006cited by this paper
• The metabolism of diclofenac--enzymology and toxicology perspectives.

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity.

  1999cited by this paper
• Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen‐induced lethality in mice: An explanation for high acetaminophen dosage in humans without hepatic injury

  1999cited by this paper
• Diclofenac Toxicity to Hepatocytes : A Role for Drug Metabolism in Cell Toxicity 1

  1998cited by this paper
• Preservation and inducibility of xenobiotic metabolism in long-term cultures of adult rat liver cell aggregates.

  1997cited by this paper
• Sulfation and glucuronidation of acetaminophen by human hepatocytes cultured on Matrigel and type 1 collagen reproduces conjugation in vivo.

  1995cited by this paper
• Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides.

  1995cited by this paper
• In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes.

  1992cited by this paper
• Use of thermospray liquid chromatography-mass spectrometry to aid in the identification of urinary metabolites of a novel antiepileptic drug, Lamotrigine.

  1991cited by this paper
• Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.

  1988cited by this paper
• Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate.

  1986cited by this paper
• Quantitative account of propranolol metabolism in urine of normal man.

  1985cited by this paper
• [3H]-Salbutamol placental transfer in pregnant rats on the 19th day of gestation.

  1982cited by this paper
• Simultaneous determination of diclofenac sodium and its hydroxy metabolites by capillary column gas chromatography with electron-capture detection.

  1981cited by this paper
• Kinetics and metabolism of paracetamol and phenacetin.

  1980cited by this paper
• Isolation and identification of the major metabolite of albuterol in human urine.

  1977cited by this paper

• In vitro recapitulation of drug metabolite partitioning into the bile and blood using the icHep system consisting of hepatocytes with an induced open-form bile canaliculus.

  2026cites this paper
• Advanced in vitro evaluation of drug-induced kidney injury using microphysiological systems in drug discovery and development.

  2025cites this paper
• Evaluating cannabidiol-induced liver injury with and without valproate using a three-dimensional human hepatocyte spheroid model.

  2025cites this paper
• In vitro technology and ADMET research in traditional Chinese medicine

  2025cites this paper
• [Frontline in Biliary Excretion of Drugs and Their Evaluation Systems].

  2025cites this paper
• Standard Protocols for Characterising Primary and In Vitro‐Generated Human Hepatocytes

  2025cites this paper
• Drug transporters in drug disposition – highlights from the year 2023

  2024cites this paper
• Expression and function of the urea cycle in widely‐used hepatic cellular models

  2024cites this paper
• Induction of open-form bile canaliculus formation by hepatocytes for evaluation of biliary drug excretion

  2023cites this paper
• Evaluating variations in bilirubin glucuronidation activity by protease inhibitors in canine and human primary hepatocytes cultured in a 3D culture system.

  2023cites this paper
• Liver three-dimensional cellular models for high-throughput chemical testing.

  2023cites this paper
• Comparative analysis of bilirubin glucuronidation activity in canine and human primary hepatocytes using a 3D culture system

  2022influential citation
• Cell Dome as an Evaluation Platform for Organized HepG2 Cells

  2022cites this paper
• Physiologically relevant microsystems to study viral infection in the human liver

  2022cites this paper
• Expression and functional activity of cytochrome P450 enzymes in human hepatocytes with sustainable reproducibility for in vitro phenotyping studies.

  2022cites this paper
• Application of Hexanoyl Glycol Chitosan as a Non-cell Adhesive Polymer in Three-Dimensional Cell Culture

  2022cites this paper
• Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data

  2021cites this paper
• Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction

  2021cites this paper
• Assessing Cytochrome P450 3A (CYP3A) Induction and Suppression Using Primary Human Hepatocyte Spheroids

  2021cites this paper
• Application and research progress of in vitro liver cancer cell culture models

  2021cites this paper
• Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project

  2021cites this paper
• In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes

  2020cites this paper
• Hepatocyte spheroids as a viable in vitro model for recapitulation of complex in vivo metabolism pathways of loratadine in humans

  2020cites this paper
• Requirements for designing organ-on-a-chip platforms to model the pathogenesis of liver disease

  2020cites this paper
• Uniform spheroid formation on a laboratory-made, low cell attachment surface consisting of a chitin sheet

  2020cites this paper
• Liver toxicity of anthraquinones: A combined in vitro cytotoxicity and in silico reverse dosimetry evaluation.

  2020cites this paper
• Development of a tunable method to generate various three-dimensional microstructures by replenishing macromolecules such as extracellular matrix components and polysaccharides

  2020cites this paper
• Integration of in vitro data from three dimensionally cultured HepaRG cells and physiologically based pharmacokinetic modeling for assessment of acetaminophen hepatotoxicity.

  2020cites this paper
• Comparative analysis of bilirubin glucuronidation activity in 2D- and 3D-cultured human hepatocellular carcinoma HepG2 cells

  2020cites this paper
• Sources of lamotrigine pharmacokinetic variability: A systematic review of population pharmacokinetic analyses.

  2020cites this paper
• Utility of Three-Dimensional Cultures of Primary Human Hepatocytes (Spheroids) as Pharmacokinetic Models

  2020influential citation
• A 3D Cell Culture Organ-on-a-Chip Platform With a Breathable Hemoglobin Analogue Augments and Extends Primary Human Hepatocyte Functions in vitro

  2020cites this paper
• High‐Precision 3D Bio‐Dot Printing to Improve Paracrine Interaction between Multiple Types of Cell Spheroids

  2020cites this paper
• Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury

  2020cites this paper
• Establishment of a primary human hepatocyte spheroid system for evaluating metabolic toxicity using dacarbazine under conditions of CYP1A2 induction.

  2019cites this paper
• A novel evaluation method for determining drug-induced hepatotoxicity using 3D bio-printed human liver tissue

  2019cites this paper
• Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury

  2019cites this paper
• Long‐term maintenance of functional primary human hepatocytes using small molecules

  2019cites this paper
• [Further investigation of 3D culture spheroid models of human hepatocytes].

  2019cites this paper
• 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications

  2019cites this paper
• Application of New Cellular and Microphysiological Systems to Drug Metabolism Optimization and Their Positioning Respective to In Silico Tools

  2019cites this paper
• Development of an alternative zebrafish model for drug‐induced intestinal toxicity

  2018cites this paper
• Qualitative and quantitative prediction of human in vivo metabolic pathways in a human hepatocyte-murine stromal cell co-culture model

  2018cites this paper
• Evaluation of the metabolic capability of primary human hepatocytes in three‐dimensional cultures on microstructural plates

  2018cites this paper
• Microscale 3D Liver Bioreactor for In Vitro Hepatotoxicity Testing under Perfusion Conditions

  2018cites this paper
• Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective

  2018cites this paper
• Human liver spheroid cultures in microfluidic chip co-cultures and comparative MetID studies

  2017cites this paper
• 3D engineered In vitro hepatospheroids for studying drug toxicity and metabolism.

  2017cites this paper
• An Automated Multiplexed Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D

  2017cites this paper
• Utility of human hepatocyte spheroids without feeder cells for evaluation of hepatotoxicity.

  2017cites this paper
• Human liver microtissue spheroids in hollow fiber membrane bioreactor.

  2017cites this paper
• Preliminary Evaluation of Three-Dimensional Primary Human Hepatocyte Culture System for Assay of Drug-Metabolizing Enzyme-Inducing Potential.

  2017cites this paper
• Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail

  2016cites this paper
• Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.

  2016cites this paper
• Determination of Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds: Comparison of a Primary Hepatocyte/Stromal Cell Co-culture with Plated Primary Hepatocytes and HepaRG

  2016cites this paper
• Development and Characterization of a Human Liver Spheroid Culture for Drug Metabolism and Disposition Studies

  2016influential citation
• In Vitro Model for Hepatotoxicity Studies Based on Primary Human Hepatocyte Cultivation in a Perfused 3D Bioreactor System

  2016cites this paper
• Metabolic activation and drug‐induced liver injury: in vitro approaches for the safety risk assessment of new drugs

  2016cites this paper
• Cell sources for in vitro human liver cell culture models

  2016cites this paper
• Modeling of aceclofenac metabolism to major metabolites in healthy volunteers.

  2016cites this paper
• Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease

  2016cites this paper
• Effects of Methoxychlor and 2,2-bis (p-Hydroxyphenyl)-1,1,1-Trichloroethane on Cytochrome P450 Enzyme Activities in Human and Rat Livers

  2015cites this paper
• 3D Cultivation Techniques for Primary Human Hepatocytes

  2015cites this paper
• Microengineered Liver Tissues for Drug Testing

  2015cites this paper
• Utility of human hepatocyte spheroids for evaluation of hepatotoxicity

  2015cites this paper
• Competency of different cell models to predict human hepatotoxic drugs

  2014cites this paper